Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Direct medical costs attributable to acute myocardial infarction and ischemic stroke in cohorts with atherosclerotic conditions CEREBROVASCULAR DISEASES Sloss, E. M., Wickstrom, S. L., McCaffrey, D. F., Garber, S., Rector, T. S., Levin, R. A., Guzy, P. M., Gorelick, P. B., Dake, M. D., Vickrey, B. G. 2004; 18 (1): 8-15

Abstract

The cost of acute ischemic events in persons with established atherosclerotic conditions is unknown.The direct medical costs attributable to secondary acute myocardial infarction (AMI) or ischemic stroke among persons with established atherosclerotic conditions were estimated from 1995-1998 data on 1,143 patients enrolled in US managed care plans.The average 180-day costs attributable to secondary AMI or stroke were estimated as USD 19,056 in the AMI cohort having a private insurance (commercial; n = 344), USD 16,845 in the AMI cohort having government insurance (Medicare, age >/=65 years; n = 200), USD 10,267 for stroke commercial (n = 108), USD 16,280 for stroke Medicare (n = 113), USD 15,224 for peripheral arterial disease commercial (n = 170), and USD 15,182 for peripheral arterial disease Medicare (n = 208).These estimates can be used to study the cost-effectiveness of interventions proven to reduce these secondary events.

View details for DOI 10.1159/000078602

View details for Web of Science ID 000222098300003

View details for PubMedID 15159615